methyl 4-(p-bromomethylphenyl)-4-oxo-butanoate | 119152-42-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 4-(p-bromomethylphenyl)-4-oxo-butanoate
• 英文别名: methyl 4-[4-(bromomethyl)phenyl]-4-oxobutanoate
• CAS: 119152-42-0
• 化学式: C₁₂H₁₃BrO₃
• 分子量: 285.137
• InChiKey: XQLRARCDMCIVSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 4-(p-bromomethylphenyl)-4-oxo-butanoate 在 盐酸 、 18-冠醚-6 、 potassium carbonate 、 锌 作用下， 以 甲苯 为溶剂， 生成
  参考文献：
  名称：

  Fluorescent stilbene, diene and triene surfactants as probes of reactivity in amylose inclusion complexes

  摘要：

  DOI：

  10.1016/s0040-4020(01)90263-7
• 作为产物：
  描述：

  4-(4-甲基苯基)-4-氧代丁酸甲酯 在 N-溴代丁二酰亚胺(NBS) 作用下， 生成 methyl 4-(p-bromomethylphenyl)-4-oxo-butanoate
  参考文献：
  名称：

  Hydrophobic-hydrophilic interactions in sodium dodecyl sulfate micelles. Stilbene-viologen complex formation as a probe of the micelle interior

  摘要：

  DOI：

  10.1021/ja00401a053

文献信息

• [EN] N-(4-(PIPERAZIN-1-YL)-PHENYL-2-OXAZOLIDINONE-5-CARBOXAMIDE DERIVATES AND RELATED COMPOUNDS AS ANTIBACTERIAL AGENTS<br/>[FR] DERIVES DE N-(4-(PIPERAZINE-1-YL)-PHENYL-2-OXAZOLIDINONE-5-CARBOXAMIDES ET COMPOSES ASSOCIES SERVANT D'AGENTS ANTIBACTERIENS
  申请人：UPJOHN CO

  公开号：WO2004045616A1

  公开（公告）日：2004-06-03

  The present invention provides antibacterial agents having the formula I described herein. or-pharmaceutically acceptable salts thereof wherein: A is a structure i, ii, iii, or iv, W is N(H)C(X)-R,. Het, or -Y HET, in which the Hot or Y HET is optionally substituted with =S or '0, provided that when A is structure iv, W is not - Y--1-MT or Het;

  本发明提供了具有以下式I的抗菌剂，或其药学上可接受的盐，其中：A是结构i、ii、iii或iv，W是N(H)C(X)-R、Het或-Y HET，在其中Hot或Y HET可以选择地被=S或'0取代，但当A是结构iv时，W不是-Y--1-MT或Het。
• Amine derivative
  申请人：Ishihara Yuji

  公开号：US20060128690A1

  公开（公告）日：2006-06-15

  The present invention provides a compound represented by the formula wherein Ar 1 is a cyclic group optionally having substituent(s); R is a hydrogen atom, an optionally halogenated C 1-6 alkyl, a phenyl optionally having substituent(s) or a pyridyl optionally having substituent(s); Ra 1 , Ra 2 , Ra 3 and Ra 4 are the same or different and each is a hydrogen atom, an optionally halogenated C 1-6 alkyl or the like; Ar is a monocyclic aromatic ring optionally having substituent(s); Y is an optionally halogenated alkylene group; and R 1 and R 2 are (1) the same or different and each is a hydrogen atom or a C 1-6 alkyl, (2) R 1 and R 2 form a nitrogen-containing heterocycle optionally having substituent(s) together with the adjacent nitrogen atom, or (3) R 1 and Y form a nitrogen-containing heterocycle optionally having substituent(s) together with the adjacent nitrogen atom, and R 2 is a hydrogen atom or a C 1-6 alkyl; provided that when the nitrogen-containing heterocycle formed by R 1 and R 2 together with the adjacent nitrogen atom is a piperazine, or when R is a C 1-4 alkyl, Ar 1 is a cyclic group having substituent(s), or a salt thereof, having a melanin-concentrating hormone antagonistic action and useful as an agent for the prophylaxis or treatment of obesity and the like.

  本发明提供了一种化合物，其表示为式子： 其中，Ar1是一个环状基团，可以具有取代基；R是氢原子，可选卤代的C1-6烷基，苯环，可以具有取代基，或者吡啶环，可以具有取代基；Ra1，Ra2，Ra3和Ra4相同或不同，每个都是氢原子，可选卤代的C1-6烷基或类似物；Ar是一个单环芳香环，可以具有取代基；Y是可选卤代的脂肪族烷基；R1和R2是（1）相同或不同，每个都是氢原子或C1-6烷基，（2）R1和R2与相邻的氮原子一起形成含氮杂环，可以具有取代基，或（3）R1和Y与相邻的氮原子一起形成含氮杂环，可以具有取代基，并且R2是氢原子或C1-6烷基；但是当R1和R2与相邻的氮原子一起形成哌嗪环，或当R是C1-4烷基，Ar1是具有取代基的环状基团或其盐时，该化合物具有黑色素浓集激素拮抗作用，可用作预防或治疗肥胖症等药物。
• AMINE DERIVATIVE
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1593667A1

  公开（公告）日：2005-11-09

  The present invention provides a compound represented by the formula wherein Ar1 is a cyclic group optionally having substituent(s); R is a hydrogen atom, an optionally halogenated C1-6 alkyl, a phenyl optionally having substituent(s) or a pyridyl optionally having substituent(s); Ra1, Ra2, Ra3 and Ra4 are the same or different and each is a hydrogen atom, an optionally halogenated C1-6 alkyl or the like; Ar is a monocyclic aromatic ring optionally having substituent(s); Y is an optionally halogenated alkylene group; and R1 and R2 are (1) the same or different and each is a hydrogen atom or a C1-6 alkyl, (2) R1 and R2 form a nitrogen-containing heterocycle optionally having substituent(s) together with the adjacent nitrogen atom, or (3) R1 and Y form a nitrogen-containing heterocycle optionally having substituent(s) together with the adjacent nitrogen atom, and R2 is a hydrogen atom or a C1-6 alkyl; provided that when the nitrogen-containing heterocycle formed by R1 and R2 together with the adjacent nitrogen atom is a piperazine, or when R is a C1-4 alkyl, Ar1 is a cyclic group having substituent(s), or a salt thereof, having a melanin-concentrating hormone antagonistic action and useful as an agent for the prophylaxis or treatment of obesity and the like.

  本发明提供了一种由式表示的化合物 其中 Ar1 是任选具有取代基的环状基团； R 是氢原子、任选卤化的 C1-6 烷基、任选具有取代基的苯基或任选具有取代基的吡啶基； Ra1、Ra2、Ra3 和 Ra4 相同或不同，各自为氢原子、任选卤代的 C1-6 烷基或类似物； Ar 是单环芳香环，可选择具有取代基； Y 是任选卤代亚烷基；以及 R1 和 R2 (1) 相同或不同，且各自为氢原子或 C1-6 烷基；(2) R1 和 R2 组成含氮杂环，可选择与相邻氮原子一起具有取代基；或 (3) R1 和 Y 组成含氮杂环，可选择与相邻氮原子一起具有取代基，且 R2 为氢原子或 C1-6 烷基； 条件是当 R1 和 R2 与相邻氮原子一起形成的含氮杂环是哌嗪时，或当 R 是 C1-4 烷基时，Ar1 是具有取代基的环状基团或其盐，具有黑色素浓缩激素拮抗作用，可用作预防或治疗肥胖症等的药物。
• Hydrophobic-hydrophilic interactions in sodium dodecyl sulfate micelles. Stilbene-viologen complex formation as a probe of the micelle interior
  作者：John C. Russell、David G. Whitten、Andre M. Braun

  DOI：10.1021/ja00401a053

  日期：1981.6
• US7601868B2
  申请人：——

  公开号：US7601868B2

  公开（公告）日：2009-10-13